Keywords: king, new, offer, alpharma, hold, pharmaceuticals, increased
King's new offer for Alpharma on hold
Article | 22 September 2008
King Pharmaceuticals has increased its offer to acquire fellow USA-based drugmaker Alpharma from the original $33 per share to $37 (Marketletter September 1), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
